Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Credit Rating

Torrent Pharmaceuticals Credit Rating

India Ratings affirmed Torrent Pharmaceuticals' existing credit ratings and revised the outlook to positive. The company's commercial paper rating was also affirmed and assigned.

Source

BSE filing, NSE: TORNTPHARM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Torrent Pharmaceuticals Ltd: key numbers

Share price
₹4,557.00
Market cap
₹1,73,334 Cr
Revenue (annual)
₹13,980 Cr
Net profit (annual)
₹2,163 Cr
P/E (TTM)
81.6×Sector 46.1×
Promoter holding
60.78%-7.53% QoQ
FII holding
17.22%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Torrent Pharmaceuticals Ltd

All →

Other credit rating announcements

All →